Page 3 - Joseph Kasper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joseph kasper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joseph Kasper Today - Breaking & Trending Today

Learning to Live in a World Without a Loved One


Learning to Live in a World Without a Loved One
How can we cope with loss and navigate the grieving process?
By
Lucy Hone
| June 2, 2021
Coping with the loss of a loved one is hard at the best of times. At the worst of times, as COVID-19 continues to ravage the planet, it can be even harder to bear. Not only has the virus caused the unexpected, sudden deaths of so many, but the circumstances accompanying those deaths and the limitations the pandemic placed on mourners have made the grieving process that much harder to navigate.
In my capacity as co-director of the New Zealand Institute of Wellbeing & Resilience, I’ve been working with companies around the world to support the resilience of their teams throughout the pandemic. The multitude of grief stories has been harrowing. Only this week I spoke to a client whose work colleague had lost four members of his family to the virus. I’ve also spent time supporting a family whose husband ....

Joseph Kasper , Laurie Anne Pearlman , David Kessler , Bob Neimeyer , Zealand Institute Of Wellbeing Resilience , University Of Pennsylvania , New Zealand Institute , Treating Traumatic Bereavement , Resilient Grieving , Abi Hone , ஜோசப் காஸ்பர் , டேவிட் கெஸ்லர் , ஜீலாந்து நிறுவனம் ஆஃப் நல்வாழ்வு விரிதிறன் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா , புதியது ஜீலாந்து நிறுவனம் ,

New inhibitors may offer novel approach to treating deadly tuberculosis


New inhibitors may offer novel approach to treating deadly tuberculosis
Zhong-Yin Zhang, head of Purdue’s Department of Medicinal Chemistry and Molecular Pharmacology, developed highly potent and selective compounds for use in the treatment of tuberculosis. (Image provided)
WEST LAFAYETTE, Ind. – Purdue University innovators have developed highly potent and selective compounds for use in the treatment of tuberculosis, which is one of the top 10 causes of death worldwide.
The Purdue researchers developed a series of small molecule inhibitors to target one of the proteins critical for the survival of TB in infected macrophages. Protein tyrosine phosphates B (mPTPB) is a virulence factor of TB to subvert the host immune responses. ....

United States , Joseph Kasper , Chris Adam , Most Innovative University , Purdue University , Us Services , Purdue Research Foundation Office Of Technology Commercialization , Purdue Department Of Medicinal Chemistry , Ipwatchdog Institute , Purdue Research Foundationoffice Of Technology Commercializationto , Association Of Public , Purdue Research Foundation , Purdue Institute For Drug Discovery , Convergence Center , Zhong Yin Zhang , Medicinal Chemistry , Molecular Pharmacology , Purdue Institute , Purdue Research Foundation Office , Technology Commercializationto , Technology Commercialization , Discovery Park District , Economic Prosperity Universities Award , Innovative University , World Report , ஒன்றுபட்டது மாநிலங்களில் ,